Cargando…

Acute onset anterior uveitis after darbepoetin alfa infusion

A 79-year-old female with a 2-month history of newly diagnosed myelodysplastic syndrome for which she received blood transfusion with darbepoetin alfa presented with bilateral anterior uveitis 1 day after her fourth transfusion. On exam, visual acuity was 20/20 in both eyes with biomicroscopy notabl...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jonathan, Orlin, Stephen E., Revere, Karen E., Kempen, John H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621975/
https://www.ncbi.nlm.nih.gov/pubmed/26502332
http://dx.doi.org/10.1186/s12348-015-0061-0
_version_ 1782397529029083136
author Li, Jonathan
Orlin, Stephen E.
Revere, Karen E.
Kempen, John H.
author_facet Li, Jonathan
Orlin, Stephen E.
Revere, Karen E.
Kempen, John H.
author_sort Li, Jonathan
collection PubMed
description A 79-year-old female with a 2-month history of newly diagnosed myelodysplastic syndrome for which she received blood transfusion with darbepoetin alfa presented with bilateral anterior uveitis 1 day after her fourth transfusion. On exam, visual acuity was 20/20 in both eyes with biomicroscopy notable for conjunctival injection and anterior chamber cell and flare consistent with anterior uveitis. She had no systemic symptoms, no history of eye trauma, and no known infections. This case, along with prior reports in the literature, suggests that anterior uveitis may be an idiosyncratic complication of darbepoetin alfa therapy.
format Online
Article
Text
id pubmed-4621975
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-46219752015-10-30 Acute onset anterior uveitis after darbepoetin alfa infusion Li, Jonathan Orlin, Stephen E. Revere, Karen E. Kempen, John H. J Ophthalmic Inflamm Infect Letter to the Editor A 79-year-old female with a 2-month history of newly diagnosed myelodysplastic syndrome for which she received blood transfusion with darbepoetin alfa presented with bilateral anterior uveitis 1 day after her fourth transfusion. On exam, visual acuity was 20/20 in both eyes with biomicroscopy notable for conjunctival injection and anterior chamber cell and flare consistent with anterior uveitis. She had no systemic symptoms, no history of eye trauma, and no known infections. This case, along with prior reports in the literature, suggests that anterior uveitis may be an idiosyncratic complication of darbepoetin alfa therapy. Springer Berlin Heidelberg 2015-10-26 /pmc/articles/PMC4621975/ /pubmed/26502332 http://dx.doi.org/10.1186/s12348-015-0061-0 Text en © Li et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Letter to the Editor
Li, Jonathan
Orlin, Stephen E.
Revere, Karen E.
Kempen, John H.
Acute onset anterior uveitis after darbepoetin alfa infusion
title Acute onset anterior uveitis after darbepoetin alfa infusion
title_full Acute onset anterior uveitis after darbepoetin alfa infusion
title_fullStr Acute onset anterior uveitis after darbepoetin alfa infusion
title_full_unstemmed Acute onset anterior uveitis after darbepoetin alfa infusion
title_short Acute onset anterior uveitis after darbepoetin alfa infusion
title_sort acute onset anterior uveitis after darbepoetin alfa infusion
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621975/
https://www.ncbi.nlm.nih.gov/pubmed/26502332
http://dx.doi.org/10.1186/s12348-015-0061-0
work_keys_str_mv AT lijonathan acuteonsetanterioruveitisafterdarbepoetinalfainfusion
AT orlinstephene acuteonsetanterioruveitisafterdarbepoetinalfainfusion
AT reverekarene acuteonsetanterioruveitisafterdarbepoetinalfainfusion
AT kempenjohnh acuteonsetanterioruveitisafterdarbepoetinalfainfusion